Cargando…
Drug Resistance in Cancer Cells
An estimated 1.5 million patients in the United States are diagnosed with cancer every year and over half-a-million individuals die of the disease. Since the vast majority of the deaths occur after medical intervention with anticancer therapy, both conventional chemotherapy and novel targeted therap...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2009.
|
| Edición: | 1st ed. 2009. |
| Temas: | |
| Acceso en línea: | Texto Completo |
Tabla de Contenidos:
- Multidrug Resistance Mediated by MDR-ABC Transporters
- Metastasis and Drug Resistance
- The Role of Autophagy and Apoptosis in the Drug Resistance of Cancer
- Mechanisms of Resistance to Targeted Tyrosine Kinase Inhibitors
- Targeting Transglutaminase-2 to Overcome Chemoresistance in Cancer Cells
- Extracellular Matrix-Mediated Drug Resistance
- Oxidative Stress and Drug Resistance in Cancer
- Nuclear Factor-?B and Chemoresistance: How Intertwined Are They?
- Drug Resistance and the Tumor Suppressor p53: The Paradox of Wild-Type Genotype in Chemorefractory Cancers
- Resistance to Differentiation Therapy
- MicroRNAs and Drug Resistance
- Molecular Signatures of Drug Resistance
- Assessment of Drug Resistance in Anticancer Therapy by Nuclear Imaging
- Overcoming Drug Resistance by Phytochemicals.